Lawrence Bellomo

A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer

Matthew J. O’Shaughnessy, Sean M. McBride, Hebert Alberto Vargas et al. · Urology · 2016 · 70 citations · Full text

Urology, Accelerate Drug Evaluations, Preclinical Drug Evaluation +9

Characterization of a Real-World Response Variable and Comparison with RECIST-Based Response Rates from Clinical Trials in Advanced NSCLC

Xinran Ma, Lawrence Bellomo, Kelly Magee et al. · Advances in Therapy · 2021 · 44 citations · Full text

Emulating Control Arms for Cancer Clinical Trials Using External Cohorts Created From Electronic Health Record‐Derived Real‐World Data

Katherine Tan, Jonathan Bryan, Brian D. Segal et al. · Clinical Pharmacology & Therapeutics · 2021 · 26 citations · Full text

Ehr Systems, Clinical Endpoint, Real-world Evidence +27

Comparison of real-world response rate (rwRR) to RECIST-based response rate in patients with advanced non-small cell lung cancer (aNSCLC)

Xinran Ma, Nathan C. Nussbaum, Kelly Magee et al. · Annals of Oncology · 2019 · 17 citations · Full text

Recist-based Response Rate, Medicine, Cancer Management +10

A phase II study combining ipilimumab and degarelix with or without radical prostatectomy (RP) in men with newly diagnosed metastatic noncastration prostate cancer (mNCPC) or biochemically recurrent (BR) NCPC.

Karen A. Autio, James A. Eastham, Daniel C. Danila et al. · Journal of Clinical Oncology · 2017 · 12 citations

Surgical Oncology, Immunodeficiencies, Phase Ii Study +18